Ensign Peak Advisors
TNDM icon

Ensign Peak Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Ensign Peak Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.9K Hold
5,032
– – ﹤0.01% 1668
2026
Q1 		$96.5K Hold
5,032
– – ﹤0.01% 1577
2025
Q4 		$111K Sell
5,032
-12,150
-71% -$219K ﹤0.01% 1548
2025
Q3 		$209K Sell
17,182
-7,800
-31% -$106K ﹤0.01% 1643
2025
Q2 		$466K Sell
24,982
-550
-2% -$10.9K ﹤0.01% 1576
2025
Q1 		$489K Hold
25,532
– – ﹤0.01% 1559
2024
Q4 		$920K Hold
25,532
– – ﹤0.01% 1370
2024
Q3 		$1.08M Hold
25,532
– – ﹤0.01% 1272
2024
Q2 		$1.03M Hold
25,532
– – ﹤0.01% 1257
2024
Q1 		$904K Sell
25,532
-1,288
-5% -$34.5K ﹤0.01% 1398
2023
Q4 		$793K Buy
26,820
+4,200
+19% +$87.1K ﹤0.01% 1508
2023
Q3 		$470K Hold
22,620
– – ﹤0.01% 1610
2023
Q2 		$555K Hold
22,620
– – ﹤0.01% 1605
2023
Q1 		$919K Buy
22,620
+50
+0.2% +$2.07K ﹤0.01% 1309
2022
Q4 		$1.01M Buy
22,570
+5,900
+35% +$267K ﹤0.01% 1151
2022
Q3 		$798K Hold
16,670
– – ﹤0.01% 1197
2022
Q2 		$987K Buy
16,670
+1,690
+11% +$139K ﹤0.01% 1113
2022
Q1 		$1.74M Hold
14,980
– – ﹤0.01% 939
2021
Q4 		$2.25M Buy
14,980
+2,080
+16% +$281K ﹤0.01% 919
2021
Q3 		$1.53M Buy
+12,900
New +$1.42M ﹤0.01% 1257
2021
Q1 		– Sell
-2,679
Closed -$256K – 1883
2020
Q4 		$256K Buy
2,679
+576
+27% +$59.4K ﹤0.01% 1695
2020
Q3 		$239K Sell
2,103
-482
-19% -$50.6K ﹤0.01% 1653
2020
Q2 		$256K Hold
2,585
– – ﹤0.01% 1557
2020
Q1 		$166K Buy
+2,585
New +$181K ﹤0.01% 1546

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ensign Peak Advisors's TNDM Position: Q2 2026 in Review

Ensign Peak Advisors held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 5,032 shares worth $75.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

Ensign Peak Advisors first reported a position in TNDM in Q1 2020 and has held it in 24 quarters since. The position peaked at $2.25M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Ensign Peak Advisors held 5,032 shares of Tandem Diabetes Care worth $75.9K as of Q2 2026.
  • Ensign Peak Advisors left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1668 holding.
  • Ensign Peak Advisors first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 24 quarters since.
  • Ensign Peak Advisors's Tandem Diabetes Care position peaked at $2.25M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.